Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients
Authors:
- 16 October 2009
- journal article
- Published by Springer Nature in Advances in Therapy
- Vol. 26 (10) , 936-946
Abstract
Studies suggest infliximab decreases hospitalization and surgery rates in Crohn’fs disease (CD). The aim of this analysis was to evaluate adherence to infliximab maintenance therapy and the impact of medication adherence on health care utilization and costs by patients with CD. Patients with CD who had at least four infliximab infusions (with the time between consecutive infusions ≤12 weeks for the first four infusions) during the first year following infliximab initiation (index date) were identified from the Integrated Health Care Information Service claims database (2002–2006). Nonadherence was defined as fewer than seven infliximab infusions in the first year. One-year health care resource utilization and costs (excluding infliximab drug and administration costs) were compared between adherent and nonadherent patients, with adjustment for baseline characteristics. A total of 571 patients with CD who were receiving infliximab maintenance therapy were identified. The infusion-based nonadherence rate was 34.3% during the first year of therapy. The multivariate analysis demonstrated that compared with adherent patients, nonadherent patients were more likely to have been hospitalized (odds ratio [OR]=2.7 [all-cause] and OR=2.5 [CD-related]; both PPP<0.001). More than one-third of patients on infliximab maintenance therapy were nonadherent to recommended maintenance. Further, nonadherence was associated with increased medical costs and a greater rate of hospitalization.Keywords
This publication has 22 references indexed in Scilit:
- PGI17 ADHERENCE TO INFLIXIMAB MAINTENANCE THERAPY AND ITS IMPACT ON HOSPITALIZATION OF PATIENTS WITH CROHN'S DISEASEValue in Health, 2008
- Review article: improving adherence to medication in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Nonadherence in inflammatory bowel disease: Results of factor analysisInflammatory Bowel Diseases, 2007
- Cardiovascular Morbidity Associated with Nonadherence to Statin TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Chronic active disease and maintaining remission in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2004
- How effective are the usual treatments for Crohn's disease?Alimentary Pharmacology & Therapeutics, 2004
- Patient Nonadherence To Medication in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2003
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Improving Chronic Illness Care: Translating Evidence Into ActionHealth Affairs, 2001